A liquid biopsy is a largely
non-invasive, sampling and analysis of liquid state biological tissue for
diagnostic and monitoring diseases such as cancer. Liquid biopsy is the direct
clinical application of two advances in medical science namely human genome
sequencing and rising sensitivity of detecting techniques and assays.
The global Liquid Biopsy market
is currently valued at $ 3950 million and will reach $ 17,372.28 million
growing at a CAGR of 28%. The growth factors responsible for this explosive
growth are liquid biopsy is a comparatively painless and non-invasive technique
which provides early real time high precision detection of diseases which could
be used for monitoring and designing effective treatment strategies based on
the real time molecular assessment for the progression of the disease. Other
factors driving the liquid biopsy market are lifestyle changes and
environmental factors such as rising investment in research and development and
collaborations between companies and public organizations, rise in population
particularly geriatric population, rising expenditure on health etc. The
technique also has other advantages over traditional tissue biopsy such as
potential applications to cardiovascular diseases, autoimmune diseases etc.
The restraints include the
prohibitive costs associated with liquid biopsy and the differential awareness
and availability between developing and the developed world. Also not all
cancer patients benefit from early detection as some cancers such as brain
cancer and prostate cancer may lie dormant for many years. Further liquid
biopsy is not all non-invasive as can be seen in case of using spinal fluid as
sample.
Key
Players for Global Liquid Biopsy market:
Guardant
Health, Inc., Trovagene, Inc., RainDance Technologies, Inc., Agena Bioscience
Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics,
Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics and
others.
Segments:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.
Segments:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.
Regional
Analysis of Global Liquid Biopsy market:
Globally
North America is the largest market for Global Liquid Biopsy market. Europe is
the second-largest market for Global Liquid Biopsy market. However the
developing regions market particularly Asia Pacific will be the fastest growing
and will be the key to the future. North America accounted for the largest
market share of 37.95% in 2016 accounting for a market value of 1,499.10
million in 2016. Asia pacific is the fastest growing market which is
growing at a CAGR of 28.8%.
The
report for Global Liquid Biopsy market of Market Research Future comprises
extensive primary research along with the detailed analysis of qualitative as
well as quantitative aspects by various industry experts, key opinion leaders
to gain the deeper insight of the market and industry performance. The report
gives the clear picture of current market scenario which includes historical
and projected market size in terms of value and volume, technological advancement,
macro economical and governing factors in the market. The report provides
details information and strategies of the top key players in the industry. The
report also gives a broad study of the different markets segments and regions.
Browse Complete 171 Pages Premium Research Report Enabled with 248
Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710
TABLE OF CONTENTS
1 Report
Prologue
2
Introduction
2.1
Definition
2.2 Scope Of
The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
2.3 Market
Structure
2.4. Market
Segmentation
3 Research Methodology
3.1 Research
Process
3.2 Primary Research
3.3
Secondary Research
5 Market Dynamics
4.1
Drivers
4.2
Restraints
4.3
Opportunities
4.4 Mega
Trends
4.5
Macroeconomic Indicators
5 Market Factor analysis
5.1 Porter’s Five Force Analysis
5.1.1 Bargaining Power Of Buyer
5.1.2 Bargaining Power Of Supplier
5.1.3 Threat From Substitute
5.1.4 Threat From A New Entrant
5.1.5 Intensity Of Competitive Rivalry
...Continued
About
US:
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment